Several mutations have been confirmed to be related to the prognosis of GIST, including KIT mutations in exons 9, 11, 13, and 17 and PDGFRA mutations in exons 12, 14, and 18 [26]. This evidence concerns the gene PDGFRA and gastrointestinal stromal tumor.